Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ENANTA PHARMACEUTICALS INC | Director | Common Stock | 5.8K | $52.9K | $9.12 | Dec 13, 2023 | Direct |
ENANTA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 15.7K | Mar 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENTA | ENANTA PHARMACEUTICALS INC | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Dec 13, 2023 | 1 | -$139K | 4 | Dec 15, 2023 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 16, 2023 | 2 | $81.2K | 4 | Mar 17, 2023 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Director |
ENTA | ENANTA PHARMACEUTICALS INC | Mar 3, 2022 | 1 | $0 | 4 | Mar 7, 2022 | Director |